Tislelizumab-related enteritis successfully treated with adalimumab: A case report

BACKGROUND: With programmed death-1 (PD-1) inhibitors becoming the standard treatment for lung cancer, PD-1-related adverse reactions and treatment have gradually become prominent. CASE SUMMARY: First reported case of tislelizumab-related enteritis successfully treated with adalimumab 40mg every 2 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Na, Qian, Min-Jia, Zhang, Ru-Hui, Gao, Qi-Qi, He, Chao-Chao, Yao, Ya-Ke, Zhou, Jian-Ying, Zhou, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561571/
https://www.ncbi.nlm.nih.gov/pubmed/36246838
http://dx.doi.org/10.12998/wjcc.v10.i28.10186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561571/
https://www.ncbi.nlm.nih.gov/pubmed/36246838
http://dx.doi.org/10.12998/wjcc.v10.i28.10186

Ejemplares similares